
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
LC–MS of various low MW cationic compounds analyzed using gradient under HILIC mode allows simultaneous analysis of multiple compounds with differences in cationic strengths.





